Ziming Du

9PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyEnvironmental epidemiologyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 02, 2026
Hypermethylation of ZNF154 promotes malignant potential of ovarian cancer cells by diminishing ZNF154/KAP1-mediated ROMO1 repression.

|Mar 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang

|Nov 24, 2025
Modulation of the PGRMC1/NLRP7/HLA-C axis by autophagy is linked to both spontaneous preterm birth and gestational choriocarcinoma.

Qin Li, Huaxiao Yu, Dongyi Ling

|Jan 03, 2024
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer.

Jennifer L Guerriero, Jia-Ren Lin, Ricardo G Pastorello

|Nov 19, 2023
Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors.

Renjing Zhang, Yang Yang, Chunfang Hu

|Sep 23, 2023
Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells.

Jiaojiao Yang, Liyue Sun, Xiao-Yun Liu

Pageof 2

Frequent Collaborators

3 joint publications

Qin Li

3 joint publications

Sandro Santagata

2 joint publications

Li-Yue Sun

2 joint publications

Fang Wang